BACKGROUND: Melanocytic nevus density is a strong risk factor for cutaneous malignant melanoma. Reducing the number of nevi in children may reduce the risk of their developing melanoma as adults. OBJECTIVE: We sought to assess the effect of sunscreen use on nevus development by anatomic sites and by nevi of different sizes for white schoolchildren in a randomized trial. METHODS: We compared the new nevus count between the sunscreen intervention group (n = 145) and the control group (n = 164) by anatomic site. RESULTS: Children randomized to the sunscreen group had significantly fewer new nevi on the trunk than children in the control group. The differences were more pronounced among the freckled children than children with no freckles. LIMITATIONS: Potential limitations to this study include relatively small numbers of enrolled children, and a follow-up period of only 3 years. CONCLUSION:Sunscreen use attenuated new nevus development on intermittently sun-exposed body sites for white schoolchildren, particularly among the freckled children.
RCT Entities:
BACKGROUND: Melanocytic nevus density is a strong risk factor for cutaneous malignant melanoma. Reducing the number of nevi in children may reduce the risk of their developing melanoma as adults. OBJECTIVE: We sought to assess the effect of sunscreen use on nevus development by anatomic sites and by nevi of different sizes for white schoolchildren in a randomized trial. METHODS: We compared the new nevus count between the sunscreen intervention group (n = 145) and the control group (n = 164) by anatomic site. RESULTS:Children randomized to the sunscreen group had significantly fewer new nevi on the trunk than children in the control group. The differences were more pronounced among the freckled children than children with no freckles. LIMITATIONS: Potential limitations to this study include relatively small numbers of enrolled children, and a follow-up period of only 3 years. CONCLUSION: Sunscreen use attenuated new nevus development on intermittently sun-exposed body sites for white schoolchildren, particularly among the freckled children.
Authors: Julia A Newton-Bishop; Yu-Mei Chang; Mark M Iles; John C Taylor; Bert Bakker; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Elaine Fitzgibbon; Faye Elliott; Peter A Kanetsky; Mark Harland; Jennifer H Barrett; D Timothy Bishop Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-07-20 Impact factor: 4.254
Authors: Haoming Xu; Michael A Marchetti; Stephen W Dusza; Esther Chung; Maira Fonseca; Alon Scope; Alan C Geller; Marilyn Bishop; Ashfaq A Marghoob; Allan C Halpern Journal: JAMA Dermatol Date: 2017-10-01 Impact factor: 10.282
Authors: Julia A Newton-Bishop; Yu-Mei Chang; Faye Elliott; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Elaine Fitzgibbon; Kairen Kukalizch; Juliette Randerson-Moor; David E Elder; D Timothy Bishop; Jennifer H Barrett Journal: Eur J Cancer Date: 2011-03 Impact factor: 9.162
Authors: John R Davies; Juliette Randerson-Moor; Kairen Kukalizch; Mark Harland; Rajiv Kumar; Srinivasan Madhusudan; Eduardo Nagore; Johan Hansson; Veronica Höiom; Paola Ghiorzo; Nelleke A Gruis; Peter A Kanetsky; Judith Wendt; Dace Pjanova; Susana Puig; Philippe Saiag; Dirk Schadendorf; Nadem Soufir; Ichiro Okamoto; Paul Affleck; Zaida García-Casado; Zighereda Ogbah; Aija Ozola; Paola Queirolo; Antje Sucker; Jennifer H Barrett; Remco van Doorn; D Timothy Bishop; Julia Newton-Bishop Journal: Pigment Cell Melanoma Res Date: 2012-03-16 Impact factor: 4.693
Authors: John R Davies; Yu-Mei Chang; Helen Snowden; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Kairen Kukalizch; Juliette Randerson-Moor; Faye Elliott; Julian Barth; Peter A Kanetsky; Mark Harland; D Timothy Bishop; Jennifer H Barrett; Julia A Newton-Bishop Journal: Cancer Causes Control Date: 2011-08-19 Impact factor: 2.506
Authors: Anne E Cust; Martin Drummond; Peter A Kanetsky; Alisa M Goldstein; Jennifer H Barrett; Stuart MacGregor; Matthew H Law; Mark M Iles; Minh Bui; John L Hopper; Myriam Brossard; Florence Demenais; John C Taylor; Clive Hoggart; Kevin M Brown; Maria Teresa Landi; Julia A Newton-Bishop; Graham J Mann; D Timothy Bishop Journal: J Invest Dermatol Date: 2018-06-08 Impact factor: 8.551